Reduced Requirement for Antibiotic Therapy Targeting Gram-Negative Organisms in Febrile, Neutropenic Patients with Cancer Who Are Receiving Antibacterial Chemoprophylaxis with Oral Quinolones

An open, nonrandomized, phase 2 study of 53 adult patients who had 60 neutropenic episodes was conducted to determine if quinolone antibacterial prophylaxis could reduce the need during febrile episodes for parenteral therapy directed at gram-negative organisms. Suspected infections among recipients...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 1995-04, Vol.20 (4), p.907-912
Main Authors: Bow, E. J., Loewen, R., Vaughan, D.
Format: Article
Language:English
Subjects:
Administration, Oral
Adult
Aged
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibacterials
Antibiotics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimicrobials
Biological and medical sciences
Bone marrow
Clinical Articles
Drug Synergism
Empirical evidence
Female
Fever
Fever - etiology
Gram-Negative Bacterial Infections - complications
Gram-Negative Bacterial Infections - prevention & control
Humans
Infections
Leukemia
Leukemia - complications
Male
Medical sciences
Middle Aged
Neutropenia - complications
Pharmacology. Drug treatments
Pilot Projects
Quinolones
Quinolones - administration & dosage
Quinolones - therapeutic use
Surveillance
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An open, nonrandomized, phase 2 study of 53 adult patients who had 60 neutropenic episodes was conducted to determine if quinolone antibacterial prophylaxis could reduce the need during febrile episodes for parenteral therapy directed at gram-negative organisms. Suspected infections among recipients of quinolones were treated empirically with vancomycin and ceftazidime; therapy with the latter was discontinued after 24–48 hours in the absence of infection due to gram-negative organisms. In five neutropenic episodes, patients had no fever or infection. An aerobic gram-negative bacillus was isolated during only 1 (1.8%) of 55 febrile episodes. Febrile episodes occurred at a median of day 15 of cytotoxic therapy. Vancomycin monotherapy was successful in 22 (50%) of 44 evaluable cases. Modification of the vancomycin regimen by the addition of metronidazole or rifampin increased the response rate to 40 (91%) of 44. Response occurred after a median of 4.5 days. Parenteral empirical therapy with amphotericin B was required in only 3 (7%) of 44 cases. The study strategy safely permitted a reduction in the amount and duration of antibiotic therapy directed against gram-negative organisms in febrile neutropenic patients.
ISSN:1058-4838
1537-6591
DOI:10.1093/clinids/20.4.907